Tender Title: Synthesis of Oligos
Reference Number: 11ecc9b44
Issuing Authority/Department: Department of Commerce, Ministry of Commerce and Industry
Scope of Work and Objectives
The Synthesis of Oligos tender aims to procure a total quantity of 10,000 oligonucleotides for research and development purposes. The oligos will be utilized in various applications including but not limited to molecular biology, genetic research, and diagnostic assays. The successful bidder will be expected to deliver high-quality oligonucleotides that meet specific criteria and standards set forth by the Department of Commerce.
Eligibility Criteria
Bidders must qualify based on the following criteria:
- Must be a registered entity with the ability to supply oligonucleotides.
- Compliance with industry standards and certifications relevant to the synthesis of oligo products.
- Financial stability to facilitate the timely procurement and delivery of goods.
Technical Requirements
The technical specifications for the oligonucleotides include:
- Synthesis of oligos with high purity, typically over 95%.
- Customization options for different lengths and modifications as per project needs.
- Proven track record in delivering oligos on time and with precise specifications.
Financial Requirements
Bidders must provide a detailed breakdown of costs associated with the synthesis and delivery of oligonucleotides. Financial documentation must illustrate the ability to meet contractual obligations, including pricing per unit and total project cost.
Document Submission Details
Bidding documents must be submitted electronically through the designated platform by the deadline stipulated in the tender notice. All submissions should include:
- Technical proposal outlining how requirements will be met.
- Financial proposal listing out costs clearly.
- Relevant certifications and compliance documentation.
Special Provisions
Micro, Small, and Medium Enterprises (MSEs) are encouraged to participate and will benefit from special provisions aimed at fostering inclusivity in government procurement. Additionally, startups meeting eligibility criteria may also avail themselves of specific advantages detailed in the tender documentation.
Evaluation Process
The evaluation will be conducted based on a two-part process:
- Technical Evaluation - Assessing the compliance of offers against the tender's technical specifications.
- Financial Evaluation - Comparison of the financial proposals after the technical evaluation completes.
Delivery Locations
The oligos must be delivered to the designated facilities provided by the Department of Commerce. Locations will be specified upon award of the tender, ensuring accessibility and convenience for procurement.
Contact Information
For inquiries regarding this tender, bidders can reach out to the procurement department of the Ministry of Commerce and Industry, ensuring they prepare their questions in advance for prompt assistance.
This overview aims to provide potential bidders with a foundational understanding of the Synthesis of Oligos tender, enabling them to prepare their submissions effectively and in alignment with the specified requirements.
General Information
Financial Information
Evaluation and Technical Information
Tender Documents
4 DocumentsDocuments Required from Seller
- Experience Criteria
- Certificate (Requested in ATC)
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Corrigendum Updates
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity with proven capability in the synthesis of oligonucleotides. Bidders must also demonstrate compliance with applicable industry standards and maintain financial stability. These prerequisites ensure that only qualified suppliers participate in the tender process.
The technical specifications necessitate the synthesis of oligonucleotides exceeding 95% purity, with customization options for varying lengths and modifications. Bidders must provide evidence of capability in meeting these standards and a track record of timely delivery to confirm compliance with the tender stipulations.
Yes, bidders must adhere to strict quality standards defined in the tender documents. Deliverables must conform to industry benchmarks for oligonucleotide synthesis, and appropriate certifications should be provided to demonstrate compliance with such quality metrics.
Payment terms will be negotiated and finalized upon award of the tender. Bidders should include their payment structure in their financial proposals, which will play a significant role in the evaluation process. Clarity on terms regarding payment timelines and methods is essential for maintaining transparency.
MSEs are provided with specific advantages within this tender framework, designed to enhance participation and support these enterprises in fulfilling government procurement needs. These benefits include preferential evaluation criteria and potential relaxation of certain requirements to foster inclusion in the tender process.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders